-
Sangamo Therapeutics (NASDAQ:SGMO) Earns "Buy" Rating from HC Wainwright
Источник: Buzz FX / 27 янв 2025 07:55:18 America/Chicago
Sangamo Therapeutics (NASDAQ:SGMO) Earns "Buy" Rating from HC Wainwright Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Sangamo Therapeutics ( NASDAQ:SGMO - Get Free Report ) 's stock had its "buy" rating restated by
Read more...